WallStSmart

Coca-Cola European Partners PLC (CCEP)vsVita Coco Company Inc (COCO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 3073% more annual revenue ($20.90B vs $658.62M). COCO leads profitability with a 12.6% profit margin vs 9.3%. CCEP trades at a lower P/E of 19.7x. COCO earns a higher WallStSmart Score of 62/100 (C+).

CCEP

Buy

57

out of 100

Grade: C

Growth: 6.7Profit: 7.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

COCO

Buy

62

out of 100

Grade: C+

Growth: 9.3Profit: 8.0Value: 4.0Quality: 8.5
Piotroski: 3/9Altman Z: 4.93

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.3/10
Return on EquityProfitability
42.9%10/10

Every $100 of equity generates 43 in profit

EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

COCO5 strengths · Avg: 9.8/10
Revenue GrowthGrowth
37.3%10/10

Revenue surging 37.3% year-over-year

EPS GrowthGrowth
61.3%10/10

Earnings expanding 61.3% YoY

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.9310/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
26.3%9/10

Every $100 of equity generates 26 in profit

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.383/10

Elevated debt levels

PEG RatioValuation
2.722/10

Expensive relative to growth rate

COCO3 concerns · Avg: 3.0/10
Price/BookValuation
12.0x4/10

Trading at 12.0x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
58.6x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity, EPS Growth, Free Cash Flow.

Bull Case : COCO

The strongest argument for COCO centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 37.3% demonstrates continued momentum.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : COCO

The primary concerns for COCO are Price/Book, Piotroski F-Score, P/E Ratio. A P/E of 58.6x leaves little room for execution misses.

Key Dynamics to Monitor

CCEP profiles as a value stock while COCO is a growth play — different risk/reward profiles.

COCO carries more volatility with a beta of 0.74 — expect wider price swings.

COCO is growing revenue faster at 37.3% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

COCO scores higher overall (62/100 vs 57/100) and 37.3% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Vita Coco Company Inc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Vita Coco Company, Inc. develops, markets, and distributes coconut water products under the Vita Coco brand in the United States, Canada, Europe, the Middle East, and Asia Pacific. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?